Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)
A prospective clinical trial evaluating DeepComp for predicting postoperative complications in gastric cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer [Phase 2]
Open-label Phase 2 trial evaluating lenvatinib with pembrolizumab or lenvatinib with pembrolizumab and FLOT as neoadjuvant/adjuvant therapy …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors [Phase 1, Phase 2]
This clinical trials update notes ongoing Phase 1/2 studies of EIK1005, a Werner helicase inhibitor, as monotherapy and in combination with …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer [Phase 2]
This clinical trial update reports a Phase 2 study using dynamic circulating tumor DNA monitoring to guide systemic therapy in gastric cance…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors [Phase 1]
This clinical trial update reports a Phase 1 dose-determining study of EXS74539 (REC-4539) in participants with select solid tumors, current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment [Phase 3]
ClinicalTrials.gov entry for a Phase 3 study of BL-M05D1 vs investigator's choice in CLDN18.2-positive advanced gastric cancer or gastroesop…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: The UGIRA International Registry for RAMIG for Gastric Cancer
Clinical Trial Update for the UGIRA International Registry for RAMIG in gastric cancer. Recruitment is ongoing at the Chinese University of …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study
This Clinical Trials update describes the FAST-GO prospective study evaluating physical function in adults receiving systemic therapy for st…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression [Phase 2]
A Phase 2, single-arm exploratory trial evaluating a triple combination of anlotinib, TQB2450, and the SOX chemotherapy regimen as first-lin…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating docetaxel, oxaliplatin, and S-1 in patients with unresectable locally advanced or lymph node–limited me…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: 18F-FAPI PET/CT and MRI in Gastric Cancer
A clinical trial evaluating 18F-FAPI PET/CT and MRI in gastric cancer, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer [Phase 2]
A Phase 2 clinical trial update examining whether beta-blockers can influence the efficacy of neoadjuvant immunotherapy in gastric cancer, c…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation [NA]
This entry provides a feasibility study update on magnetic sentinel lymph node mapping for upper gastrointestinal cancers, focusing on gastr…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers. [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and activity of S095029 in combination therapy for advanced gas…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum [Phase 1, Phase 2]
Phase 1/2 window-of-opportunity study evaluating intraperitoneal TROP2 CAR/IL-15 TGFBR2 KO natural killer (NK) cells for managing gastric ca…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer [Phase 2]
Phase 2 clinical trial update on zolbetuximab (IMAB362) in adults with gastric cancer, including pharmacokinetic data and current non-recrui…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC) [Phase 3]
This is a Phase 3 clinical trial evaluating the efficacy and safety of ferric carboxymaltose in patients with advanced gastric cancer; the s…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer [Phase 3]
This entry reports a Phase 3 clinical trial evaluating zolbetuximab in combination with pembrolizumab and chemotherapy for gastric cancer an…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06) [Phase 1, Phase 2]
This document describes Substudy 06D of a Phase 1/2 clinical trial evaluating pembrolizumab in combination therapies for second-line gastroe…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating dynamic ctDNA-guided adjuvant therapy for stage III and IV gastric or gastroesophageal junction adenocarcinoma; cur…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) [Phase 2, Phase 3]
A Phase 2/3 clinical trial (ROSETTA Gastric-204) is evaluating Pumitamig plus chemotherapy versus Nivolumab plus chemotherapy as first-line …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions
This clinical trial compares the sensitivity of probe-based confocal laser endomicroscopy (pCLE) against traditional pathological biopsy for…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment [Phase 3]
Phase 3 clinical trial evaluating the feasibility of using circulating tumor DNA–based minimal residual disease to guide adjuvant therapy in…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41
A Spanish validation study (SPQUSS-41) is evaluating the KOQUSS-40 questionnaire to measure quality of life in gastric cancer patients after…